Page 134 - Read Online

Ibrahim et al ALDHs and prostate cancer

EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer significance of serum alcohol dehydrogenase isoenzymes and
development. Mod Pathol 2011;24:786-93. aldehyde dehydrogenase activity in urinary bladder cancer patients.
43. Burgos-Ojeda D, Rueda BR, Buckanovich RJ. Ovarian cancer stem Anticancer Res 2017;37:3537-41.
cell markers: prognostic and therapeutic implications. Cancer Lett 61. Yan J, De Melo J, Cutz JC, Aziz T, Tang D. Aldehyde dehydrogenase
2012;322:1-7. 3A1 associates with prostate tumorigenesis. Br J Cancer
44. Chen Y, Orlicky DJ, Matsumoto A, Singh S, Thompson DC, 2014;110:2593-603.
Vasiliou V. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential 62. Le Magnen C, Bubendorf L, Rentsch CA, Mengus C, Gsponer J,
biomarker for human colon cancer. Biochem Biophys Res Commun Zellweger T, Rieken M, Thalmann GN, Cecchini MG, Germann M,
2011;405:173-9. Bachmann A, Wyler S, Heberer M, Spagnoli GC. Characterization
45. Pors K, Moreb JS. Aldehyde dehydrogenases in cancer: an and clinical relevance of ALDHbright populations in prostate cancer.
opportunity for biomarker and drug development? Drug Discov Clin Cancer Res 2013;19:5361-71.
Today 2014;19:1953-63. 63. Doherty RE, Haywood-Small SL, Sisley K, Cross NA. Aldehyde
46. Rodriguez-Torres M, Allan AL. Aldehyde dehydrogenase as a marker dehydrogenase activity selects for the holoclone phenotype in prostate
and functional mediator of metastasis in solid tumors. Clin Exp cancer cells. Biochem Biophys Res Commun 2011;414:801-7.
Metastasis 2016;33:97-113. 64. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger
47. Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase RC, van der Pluijm G. The aldehyde dehydrogenase enzyme 7A1 is
1A1 in stem cells and cancer. Oncotarget 2016;7:11018-32. functionally involved in prostate cancer bone metastasis. Clin Exp
48. Liu Y, Lv DL, Duan JJ, Xu SL, Zhang JF, Yang XJ, Zhang X, Metastasis 2011;28:615-25.
Cui YH, Bian XW, Yu SC. ALDH1A1 expression correlates with 65. Wang S, Liang C, Bao M, Li X, Zhang L, Li S, Qin C, Shao P, Li
clinicopathologic features and poor prognosis of breast cancer J, Hua L, Wang Z. ALDH1A3 correlates with luminal phenotype in
patients: a systematic review and meta-analysis. BMC Cancer prostate cancer. Tumour Biol 2017;39:1010428317703652.
2014;14:444. 66. Casanova-Salas I, Masia E, Arminan A, Calatrava A, Mancarella
49. Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, C, Rubio-Briones J, Scotlandi K, Vicent MJ, Lopez-Guerrero JA.
Kumar B, Wainer Z, Brown T, Schneider-Kolsky M, Conron M, MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate
Wright G, Watkins DN. The prognostic significance of aldehyde cancer. PLoS One 2015;10:e0125576.
dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early 67. Trasino SE, Harrison EH, Wang TT. Androgen regulation of aldehyde
stage non-small cell lung cancer. Thorax 2013;68:1095-104. dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive
50. Kahlert C, Bergmann F, Beck J, Welsch T, Mogler C, Herpel E, human prostate cancer cell line LNCaP. Exp Biol Med (Maywood)
Dutta S, Niemietz T, Koch M, Weitz J. Low expression of aldehyde 2007;232:762-71.
deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor 68. Myers JS, von Lersner AK, Sang QX. Proteomic upregulation of
survival in pancreatic cancer. BMC Cancer 2011;11:275. fatty acid synthase and fatty acid binding protein 5 and identification
51. Kim H, Lapointe J, Kaygusuz G, Ong DE, Li CD, van de Rijn M, of cancer- and race-specific pathway associations in human prostate
Brooks JD, Pollack JR. The retinoic acid synthesis gene ALDH1a2 cancer tissues. J Cancer 2016;7:1452-64.
is a candidate tumor suppressor in prostate cancer. Cancer Res 69. Casanova-Salas I, Masia E, Arminan A, Calatrava A, Mancarella
2005;65:8118-24. C, Rubio-Briones J, Scotlandi K, Vicent MJ, Lopez-Guerrero JA.
52. Li T, Su Y, Mei YP, Leng QX, Leng BJ, Liu ZQ, Stass SA, Jiang F. MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate
ALDH1A1 is a marker for malignant prostate stem cells and predictor cancer. PLoS One 2015;10:e0125576.
of prostate cancer patients’ outcome. Lab Invest 2010;90:234-44. 70. Lonergan PE, Tindall DJ. Androgen receptor signaling in prostate
53. Li XS, Xu Q, Fu XY, Luo WS. ALDH1A1 overexpression is cancer development and progression. J Carcinog 2011;10:20.
associated with the progression and prognosis in gastric cancer. BMC 71. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner
Cancer 2014;14:705. PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL. Altered
54. Touma SE, Perner S, Rubin MA, Nanus DM, Gudas LJ. Retinoid expression of androgen receptor in the malignant epithelium and
metabolism and ALDH1A2 (RALDH2) expression are altered in adjacent stroma is associated with early relapse in prostate cancer.
the transgenic adenocarcinoma mouse prostate model. Biochem Cancer Res 2001;61:423-7.
Pharmacol 2009;78:1127-38. 72. Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing
55. Yang T, Rycaj K, Liu Z, Tang DG. Cancer stem cells: constantly P, Stahl J, Marshall VR, Horsfall DJ, Tilley WD. Androgen receptor
evolving and functionally heterogeneous therapeutic targets. Cancer levels in prostate cancer epithelial and peritumoral stromal cells
Res 2014;74:2922-7. identify non-organ confined disease. Prostate 2005;63:19-28.
56. Leach DA, Buchanan G. Stromal androgen receptor in prostate 73. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R,
cancer development and progression. Cancers (Basel) 2017;9: E10. Rosenfeld MG, Sawyers CL. Molecular determinants of resistance to
57. Cunha GR, Chung LW. Stromal-epithelial interactions--I. Induction antiandrogen therapy. Nat Med 2004;10:33-9.
of prostatic phenotype in urothelium of testicular feminized (Tfm/y) 74. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-
mice. J Steroid Biochem 1981;14:1317-24. Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder
58. Donjacour AA, Cunha GR. The effect of androgen deprivation FH, van der Kwast TH. Androgen receptor status in localized and
on branching morphogenesis in the mouse prostate. Dev Biol locally progressive hormone refractory human prostate cancer. Am J
1988;128:1-14. Pathol 1994;144:735-46.
59. Kunju LP, Cookingham C, Toy KA, Chen W, Sabel MS, Kleer CG. 75. Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C.
EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer Nuclear localization of androgen receptor in heterogeneous samples
development. Modern Pathol 2011;24:786-93. of normal, hyperplastic and neoplastic human prostate. J Urol
60. Orywal K, Jelski W, Werel T, Szmitkowski M. The diagnostic 1992;147:798-803.

12 Journal of Cancer Metastasis and Treatment ¦ Volume 4 ¦ Aug 21, 2018